Who We Fund
Since 1949, LLS has provided more than $1.7 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Daniel Lucas
bone marrow and leukemia biology
Ruben Carrasco
Myeloma
Robert Kridel
follicular lymphoma
Dane Vassiliadis
blood cancer biology
Jolanta Grembecka
leukemia therapeutics
Catherine Smith
leukemia
Therese Vu
T-All and MLL
Jennifer Trowbridge
aging and leukemia
Ann-Kathrin Eisfeld
Racial diversity in AML
Nizar Bahlis
Myeloma immunotherapy
Susan Schwab
cancer immunology
Lindsey Montefiori
pediatric leukemia
Michael Savona
MDS and leukemia
Jeremy Baeten
AML
Caroline Arber
myeloma CAR-T
Peng Ji
myeloproliferative neoplasms
G. Greg Wang
DNA biology
Thorsten Zenz
Hairy cell leukemia
Jayna Mistry
aging and leukemias
Kirsten Williams
leukemia, immunotherapy
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Michael Keller
COVID-19, immunotherapy
Hong Wen
AML
Alieen Rowan
Adult T cell leukemia/lymphoma
ImCheck Therapeutics
immunotherapy, AML
Matthew Frank
Lymphoma CART therapy
Daniel Thomas
Myelofibrosis
Stacie Dusetzina
Equity in Access
Brian Walker
smoldering myeloma, MGUS
Dan Landau
cancer evolution biology
Liran Shlush
pre-leukemia
Kirk Schultz
pediatric transplantation
Helen Heslop
Immunotherapy
Ricky Johnstone
lymphoma and myeloma
Mitchell Geer
leukemia biology
Aditi Shastri
AML, MDS
Tomasz Skorski
myeloproliferative neoplasms, AML
Jennifer Lewis
URM Student
Sigurður Kristinsson
Smoldering myeloma
Bruno Paiva
smoldering myeloma
Lori Muffly
Equity in Access
Jian Xu
leukemia and MPN biology
Lawrence Boise
CART and myeloma
Sattva Neelapu
DLBCL, CAR T
Jeffrey Magee
pediatric AML
Paolo Strati
Non-Hodgkin Lymphoma
Jianhua Yu
myeloma immunotherapy
Ryan Wilcox
T-cell lymphoma
Caron Jacobson
lymphoma and immunotherapy
Qingyu Luo
BPDCN
Helen Parsons
Equity in Access
Martin Dreyling
Mantle Cell Lymphoma
Nicolas Nassar
pediatric leukemia
Jonathon Cohen
lymphoma clinical trial access in Georgia
Enterome
vaccine, FL, MZL
Carl June
CAR T immunotherapy
Arash Alizadeh
blood cancer biology and diagnosis
Maximilian Stahl
AML immunotherapy
Jianguo Tao
Mantle Cell Lymphoma
Luca Busino
DLBCL
Meng Li
Equity in Access
Kevin Shannon
pediatric AML
Dimericon Therapeutics
dimericons, blood cancer
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Trent Hall
MDS
Stephen Oh
myeloproliferative neoplasms
Constellation Pharmaceuticals
myeloproliferative neoplasms
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Noemí Puig Morón
Myeloma
Amit Verma
AML/MDS
George Vassiliou
Leukemia Prevention
Jaroslaw Maciejewski
bone marrow failure
John Crispino
MPNs, myelofibrosis
Tyler Parsons
MPN and AML
Carl Allen
pediatric blood cancers
Sam Butterworth
CMML
Suman Paul
T cell cancers and immunotherapy
Nirav Shah
CAR-T for lymphoma
Christiane Querfeld
T-cell lymphoma
Thomas Koehnke
leukemia
F. Lennie Wong
Equity in Access
David Fruman
novel combinations
Christopher Porter
Leukemia, lymphoma
Gianpietro Dotti
CAR T and AML
Rgenta Therapeutics
RNA-targeting, blood cancer
Baochun Zhang
immunotherapy
Maria "Ken" Figueroa
aging and leukemia
Adam Olszewski
Follicular and marginal zone lymphoma
Marina Konopleva
MDS/AML metabolism
Julia Paczkowska
immunobiology of Hodgkin's disease
William Matsui
Myeloma
Mark Hamilton
DLBCL and CAR-T
Liling Wan
AML
Christopher Flowers
clinical trial access
Abintus Bio
immunotherapy, in vivo CAR
Randall Davis
CLL
Alec Zhang
myeloma, immunotherapy
Daniel Starczynowski
MDS and AML
Tak Mak
Immunotherapy
Jessica Stewart
Epstein-barr virus and lymphomas
Sean Post
diffuse large B-cell lymphoma
Kasey Leger
pediatric blood cancers
Sahand Hormoz
MPN
Armin Rashidi
gut bacteria and transplant success
Qing Yi
Novel CAR-T
Coleman Lindsley
AML/MDS
Koichi Takahashi
AML/MDS
Jun Qi
Myeloma
Simona Colla
Myeloma biology
Rizwan Romee
Immunotherapy
Cailin Collins
Leukemia and pre-leukemia
Adi Nagler
Bronchiolitis obliterans after transplant
Taishi Yonezawa
AML
Brian Dalton
DNA mutations and myeloid cancers
Ari Melnick
epigenetics and lymphoma
Stephen Nimer
myeloid cancer biology
Srividya Swaminathan
pediatric, immunotherapy
Timothy Ley
AML, precision medicine
Jason Butler
aging and leukemia
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Daniel Herranz
T-ALL
Courtney DiNardo
clinical trials, AML
Soheil Meshinchi
pediatric AML
Enrico Tiacci
Hairy cell leukemia
Gaurav Goyal
Erdheim-Chester Disease
Thomas Kipps
Hairy Cell Leukemia
Nitin Jain
CLL
Sameer Parikh
COVID-19
Faron Pharmaceuticals
immunotherapy, MDS
Daisuke Nakada
preleukemia, leukemia
Richard Lock
T-ALL
Shannon Maude
Immunotherapy for ALL
Matteo Bellone
Smoldering multiple myeloma
Kerry Rogers
CLL
Tycel Phillips
Mantle Cell Lymphoma
Frederike Kramer
MPNs
Christine Zhang
AML
Keisuke Ito
blood cancer stem cells and MDS metabolism
Ronald Levy
immunotherapies, COVID-19
Nathan Ungerleider
lymphoma biology
Christopher Booth
BPDCN
Jalpa Doshi
Equity in Access
Daniel Pollyea
AML
Eirini Papapetrou
blood cancer stem cells
Ryvu Therapeutics
AML, MDS
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Steven Treon
Lymphomas and Waldenstrom's
Zachary Hunter
Waldenström macroglobulinemia (WM)
Robert Bradley
MDS
Zhijian Qian
blood cancer stem cells
Selina Chen-Kiang
Mantle cell lymphoma
Gareth Morgan
smoldering myeloma, MGUS
Lev Kats
myeloma and epigenetics
Joachim Yahalom
Lymphoma
Michael Kharas
leukemia
Xu Ji
Equity in Access
Adam de Smith
pediatric ALL and Down Syndrome
Michael Green
lymphoma biology
Alexey Danilov
lymphoma
Mark Dawson
B-ALL and CAR-T resistance
Julia Maxson
AML
Yibin Yang
Lymphoma
Yubin Zhou
peripheral T cell lymphoma
Thomas LeBlanc
palliative care
John Leonard
lymphoma research
Robert Orlowski
(Smoldering) Multiple Myeloma
Michael Wang
Mantle Cell Lymphoma
Saar Gill
AML immunotherapy
Jenny Wang
AML
Sarah Tasian
pediatric leukemias
Kymera Therapeutics
protein degraders, TCL, LGLL, AML
Shannon McKinney-Freeman
transplant biology
Eric Pietras
AML
Suzanne Lentzsch
Myeloma
Robert Soiffer
transplantation
Lucy Godley
preleukemia
Larry Kwak
Mantle cell lymphoma, immunotherapy
Catherine Bollard
pediatric blood cancers and immunotherapy
Madhav Dhodapkar
multiple myeloma immunotherapy
Peter Klein
MDS
Margaret Shipp
lymphoma biology
Kura Oncology
MLL leukemia, AML
Christian Steidl
B-cell lymphomas
Rong Lu
preleukemia, leukemia
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Jing Yang
Myeloma
Lakshmi Nayak
brain tumors in lymphoma
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Areej El-Jawahri
transplant survivorship
BioInvent International
immunotherapy, indolent NHL, CTCL
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Kimberly Stegmaier
childhood blood cancers
Eugenio Morelli
Myeloma
Caner Saygin
T-ALL
Alison Moskowitz
lymphoma therapeutics
Wendy Béguelin
follicular lymphoma
Juliette Bouyssou
leukemias and gender
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Ravi Bhatia
transplantation
Mendel Goldfinger
MDS/AML trials for the elderly
Sami Malek
blood cancer biology
Venkata Lokesh Battula
immunotherapy and AML
Mala Shanmugam
myeloma
Neha Mehta-Shah
T-cell lymphoma
Jonathan Licht
DNA biology, myeloma
Jonas Jutzi
myeloproliferative neoplasms
Piers Patten
COVID-19
Kathleen Sakamoto
pediatric AML
Siddhartha Jaiswal
preleukemia
Markus Muschen
leukemia and lymphoma biology
Rajni Kumari
AML
Wendy Stock
T-cell ALL
Kehan Ren
MDS
Frederick Locke
lymphoma and immunotherapy
Amer Zeidan
MDS and AML
Megan McNerney
AML/MDS
Marco Ruella
Immunotherapy for T-cell lymphoma
Omar Abdel-Wahab
Hairy cell leukemia
Courtney Jones
AML metabolism
Huda Salman
CMML
Riccardo Dalla-Favera
lymphoma (DLBCL)
Sisi Chen
leukemia
Steven Horwitz
T-cell lymphomas
Britta Will
Leukemia and pre-leukemia
Jaehyuk Choi
T-cell lymphoma
Amin Sobh
Myeloma biology
Tanya Siddiqi
clinical trial access
Alex Herrera
lymphoma and immunotherapy
Roland Walter
Antibody-based AML therapies
Catriona Jamieson
cancer stem cell biology
Elliot Stieglitz
CMML
Reshmi Parameswaran
immunotherapy for hairy cell leukemia
Shirong Li
myeloma
Jennifer Woyach
CLL trials
Eric Padron
CMML
Takeshi Sugio
T-cell lymphoma
Ravindra Majeti
preleukemia, AML
Stephen Gottschalk
pediatric leukemia and CAR-T
Andrew Lane
BPDCN
Justine Kahn
pediatric leukemia and lymphoma
Katherine Borden
AML
Yan Liu
MDS
Grant Challen
preleukemia, leukemia
Marc Seifert
Hairy cell leukemia
Grzegorz Nowakowski
Clinical trial access
Hao Jiang
leukemia biology
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Sergei Doulatov
Leukemias
Oreofe Odejide
Equity in Access
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Logan Spector
childhood leukemia epidimiology
Yusuke Isshiki
DLBCL and GCB Lymphomas
Yiman Liu
Epigenetics and leukemia
Alex Kentsis
pediatric leukemias
Timothy Graubert
AML and MDS biology
Michael Rout
follicular lymphoma, CAR T
Christian Marinaccio
MLL leukemias
Craig Jordan
AML
Samuel Taylor
leukemia biology
Alfred Garfall
myeloma immunotherapy
Affimed
immunotherapy, HL, PTCL
Pietro Genovese
transplant and AML
Inhye Ahn
CLL
Roberta Zappasodi
lymphoma, immunotherapy